BRAoVO™ Colorectal/Endometrial Gene Panel

Genetic panel for colorectal, polyposis, gastric and endometrial inherited cancer risk

Test description

Testing of genes associated with hereditary colorectal, polyposis, gastric endometrial, cancer syndromes in patients with relevant personal or family history.

Test information

Test name

BRAoVOTM Colorectal/Endometrial Gene Panel

Clinical indication

Testing for patients with colorectal and/orendometrial cancer, or a personal or family history suggestive of a hereditarycolorectal or endometrial cancer syndrome. Results may confirm a diagnosis, tailorsurveillance, determine prophylactic surgery and initiate family testing.

Gene(s)

APC, ATM, AXIN2, BMPR1A, CDH1, CHEK2, CTNNA1, EPCAM, GREM1, KIT, MLH1, MLH3, MSH2, MSH3, MSH6, MUTYH, NTHL1, PMS2, POLD1, POLE, PTEN, RNF43, SCG5, SMAD4, STK11, TP53

Method

Massively parallel sequencing

Turn around time

4 - 5 weeks

Medicare eligibility

73354 – conditions apply

73355 – conditions apply

73356 - conditions apply

Price

$575 if not Medicare eligible

Test request form

Cancer Genetics Request form preferred. Standard pathology request form accepted.

Sample type

Blood x 2

Collection type

EDTA

Special instructions

2 x Bloods taken at 10 minute intervals. Pre-test genetic counselling required. Patient to consent to genetic testing prior to laboratory testing.

FAQ

No items found.

Resources

No items found.